PHARVARIS NV

Pharvaris Shares Plunge 7% to €27.50 Amid Rising Risk and Sector Volatility

Pharvaris NV shares slump 6.98% amid clinical‑stage uncertainty; market cap €1.7bn, price just above 200‑day MA—investors watch trial updates closely.

PHARVARIS NV
Netherlands
Health Care
Pharmaceuticals, Biotechnology & Life Sciences
AI generated

Jake Connors

20/10/2026, 22:57

3 minutes to read